Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of HEALIOS K.K.. A complete text table follows the diagram.
New shares and Saisei Fund contributions funded a regenerative-medicine platform still operating far ahead of commercial revenue.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Proceeds from issuance of shares | 1 | 3.9B | 77.7% of reported total |
| Contributions from third-party investors in Saisei Fund | 1 | 1.1B | 22.3% of reported total |
| Gross net cash provided by used in financing activities | 2 | 5.0B | Reported six-month total · ¥5.0B |
| Net Cash Provided By Used In Financing Activities | 3 | 4.9B | Reported consolidated total |
| Eliminations & reconciliation | 3 | 61M | Reported dimensional reconciliation |
| Operating loss | 3 | 1.6B | Absolute value of reported operating loss |
| Operating costs & expenses | 4 | 6.5B | Revenue plus reported operating loss |
| From | To | Value |
|---|---|---|
| Proceeds from issuance of shares | Gross net cash provided by used in financing activities | 3.9B |
| Contributions from third-party investors in Saisei Fund | Gross net cash provided by used in financing activities | 1.1B |
| Gross net cash provided by used in financing activities | Net Cash Provided By Used In Financing Activities | 4.9B |
| Gross net cash provided by used in financing activities | Eliminations & reconciliation | 61M |
| Net Cash Provided By Used In Financing Activities | Operating costs & expenses | 4.9B |
| Operating loss | Operating costs & expenses | 1.6B |